Table 1.

Comparison of binding performances of the previously reported affinity materials.

Material	Ligand	Ligand density	Target protein	Binding capacity	Ref.
Sepharose beads	AviPure ligand	429 nmol/g	IgG	53 mg/mL	38
Agarose-OPS adsorbent		31.93 mg/mL	IgG	24.2 mg/mL	23
Porous membranes containing immobilized peptide	KGSGSGSQLGPYELWELSH (KH19)	5.1 ± 1.3 mg/mL	Trastuzumab	1.3 ± 0.3 mg/mL	37
Peptide immobilized monolith	HHHHHHGSGSGSQLGPYELWELSH (HH24)	11 mg/mL	Trastuzumab	16.4 mg/g	13
Peptide immobilized monolith	Fmoc-HWEGWV	155 μmol/mL	IgG	101.8 mg/mL	39
Fe3O4@SiO2 magnetic nanoparticles	Protein A	203 mg/g	anti-EGFR mAb	112.3 mg/g	24
Peptide immobilized monolith	Histidine-tagged cyclic peptide	13.8 mg/mL	IgG	119.3 mg/g	11
His-MWNTs	l-Histidine	210 μmol/g	IgG	267.8 mg/g	40
Porous membranes containing immobilized peptide	KGSGSGSWPRWLEN (KN14)	/	Rituximab	16.5 mg/mL	19
Fe3O4@NiFe LDH@HN19 Fe3O4@NiFe LDH@HE24	HN19 HE24	2467 mg/g 2382 mg/g	Rituximab Rituximab	1375 mg/g 1194 mg/g	This work